The Kind-Philipp-Meeting was established as a scientific and educational program at the interface of basic and clinical research in pediatric hematology and oncology. Advances in molecular techniques and immunotherapy are rapidly causing novel insights into the biology and therapeutic perspectives of pediatric cancer. Diagnoses using molecular techniques are also allowing us to distinguish distinct subgroups within cancer types and to identify patients with different disease behavior and prognosis.
The Kind-Philipp-Meeting covers all these aspects of pediatric hematology and oncology, including molecular and functional features of cancer cells, the role of somatic and germ-line mutations and epigenetic alterations in the biology and pathogenesis of cancer, advances in molecular diagnostics and novel therapeutic agents. The interactive nature of the meeting allows PhD students, postdocs and medical students from all over Europe to share their novel and unpublished biological, genomic, epigenetic or clinical data on leukemias and solid cancers.
Two keynote lectures from internationally renowned scientists will provide an overview of the status of the field and novel insights into cutting-edge technologies and cancer pathogenesis.
The Kind-Philipp-Meeting promotes informal interaction and ample discussion between young and established scientists and clinicians working in the field. The target audience will comprise of leading scientists, PhD students, medical students, basic scientists, physician-scientists, as well as clinicians with an interest in the field.